Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Marie-Laetitia Thezenas et al from the Kessler group in collaboration with NDORMS and Bayer shows in a very elegant, combined proteomics and transcriptomic study the relevance of AOC3 / VAP1 for oxidative stress and inflammation in endometriosis.

The team nicely demonstrated downregulation of protective, anti-oxidant factors while pro-oxidative enzymes were increased in human endometriosis samples. Notably, an AOC3 enzyme inhibitor was able to reduce pro-inflammatory pain, suggesting potential translational relevance.